Our Organization BHB Therapeutics, Ltd.
Our Organization BHB Therapeutics, Ltd.
Lavender Swirl Background
Partner

BHB Therapeutics, Ltd.

Dementia and neurodegenerative conditions are a tremendous burden on our healthcare system and economy.



BHB Therapeutics, Ltd. is a joint partnership between Juvenescence and The Buck Institute for Research on Aging.

The company will focus on novel approaches to inducing a state of ketosis, which may have protective effects against age-related disease. Ketosis is the state where the body burns fat instead of carbohydrates, increasing the production of anti-inflammatory ketone bodies.

The work is based on the research in the labs of Drs. Eric Verdin, MD and John Newman, MD, PhD. This work centers on the emerging signaling functions of a metabolite created by the body during fasting or exercise, the ketone body beta-hydroxybutyrate (BHB). They have discovered that BHB helps the body respond to stresses, and that long-term exposure to ketone bodies following a ketogenic diet can extend healthy lifespan in model systems.

BHB Therapeutics is part of our continuing commitment to develop and bring products to consumers that have a strong evidence of providing scientific benefit to an aging population.

In the News

BHB Therapeutics

Juvenescence and the Buck Institute launch BHB Therapeutics

Juvenescence and the Buck Institute for Research on Aging announce a new collaboration with the formation of BHB Therapeutics a joint venture.

February 3, 2019

Read More

Contact Us

We are here to help answer any questions you might have.